Treatment of Anemia and Neutropenia in HIV/HCV Coinfected Patients Treated With Pegylated Interferon and Ribavirin

• Status: Terminated
• Trial end date: 2005-12-01
• Target enrollment: 0
• Participant gender: All

Summary

This study is designed to test two separate strategies for treatment of anemia (low hemoglobin) and neutropenia (low white blood cells) in HIV/HCV coinfected patients who are being treated with pegylated interferon and ribavirin.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Weill Medical College of Cornell University
• Collaborator: Schering-Plough
• Treatments: Epoetin Alfa; Interferons; Ribavirin

Criteria

Inclusion Criteria:

• hemoglobin > 11

• absolute neutrophil count >1,200

• naive to peg interferon and ribavirin

Exclusion Criteria:

• Prior treatment for hepatitis C

• Pregnant or nursing